Florence Boissière-Michot Selected Research

Florence Boissière-Michot Research Topics

Disease

26	Neoplasms (Cancer) 01/2024 - 03/2009
11	Breast Neoplasms (Breast Cancer) 09/2022 - 03/2009
10	Triple Negative Breast Neoplasms 01/2024 - 01/2019
9	Colorectal Neoplasms (Colorectal Cancer) 03/2024 - 09/2006
4	Neoplasm Metastasis (Metastasis) 04/2023 - 09/2006
3	Carcinogenesis 03/2024 - 09/2021
3	Adenocarcinoma 01/2021 - 05/2012
2	Rectal Neoplasms (Rectal Cancer) 12/2011 - 06/2011
1	Colonic Neoplasms (Colon Cancer) 03/2024
1	Inflammation (Inflammations) 09/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021
1	Colitis-Associated Neoplasms 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2020
1	Melanoma (Melanoma, Malignant) 01/2017
1	Microsatellite Instability 08/2016
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2016
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 03/2009
1	Disease Progression 03/2009
1	Metaplasia 01/2008

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 03/2024 - 08/2016
6	Biomarkers (Surrogate Marker)IBA 06/2022 - 12/2011
4	Cathepsin DIBA 01/2024 - 01/2019
4	Messenger RNA (mRNA)IBA 01/2023 - 06/2011
3	Peptide Hydrolases (Proteases)FDA Link 01/2024 - 01/2019
3	AntibodiesIBA 01/2024 - 01/2017
3	Cetuximab (Erbitux)FDA Link 01/2021 - 09/2006
2	Transcription Factors (Transcription Factor)IBA 03/2024 - 09/2021
2	Hormones (Hormone)IBA 09/2022 - 07/2020
2	Androgen Receptors (Androgen Receptor)IBA 12/2021 - 05/2020
2	Phenobarbital (Luminal)FDA Link 11/2021 - 05/2020
2	Chemokine ReceptorsIBA 05/2021 - 07/2020
2	ChemokinesIBA 05/2021 - 07/2020
2	Trastuzumab (Herceptin)FDA Link 01/2021 - 03/2009
2	Irinotecan (Camptosar)FDA LinkGeneric 12/2020 - 03/2009
2	Monoclonal AntibodiesIBA 01/2017 - 05/2012
2	DNA (Deoxyribonucleic Acid)IBA 01/2013 - 05/2012
2	ErbB Receptors (EGF Receptor)IBA 05/2012 - 09/2006
1	Carrier Proteins (Binding Protein)IBA 03/2024
1	Nuclear Receptor Co-Repressor 1IBA 03/2024
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2024
1	enzalutamideIBA 01/2024
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2023
1	SteroidsIBA 09/2022
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 09/2022
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 06/2022
1	Plasminogen InactivatorsIBA 06/2022
1	Plasminogen Activators (Plasminogen Activator)IBA 06/2022
1	poliovirus receptorIBA 01/2022
1	Nuclear Receptor Interacting Protein 1IBA 09/2021
1	Cyclin A2IBA 01/2021
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021
1	Gemcitabine FDA Link 01/2021
1	Sorafenib (BAY 43-9006)FDA Link 12/2020
1	LigandsIBA 07/2020
1	Estrogen ReceptorsIBA 05/2020
1	Keratin-5 (Keratin 5)IBA 05/2020
1	BRCA1 ProteinIBA 03/2020
1	B7-H1 AntigenIBA 03/2020
1	Caspase 3 (Caspase-3)IBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	MEHD7945AIBA 01/2020
1	Interleukin-8 (Interleukin 8)IBA 01/2020
1	Adenosine (Adenocard)FDA LinkGeneric 01/2020
1	CateninsIBA 12/2019
1	Protein Kinases (Protein Kinase)IBA 12/2019
1	Cadherins (E-Cadherin)IBA 12/2019
1	Syk KinaseIBA 12/2019
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2017
1	ElementsIBA 02/2016
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 02/2016
1	Prostaglandins DIBA 01/2016
1	Formaldehyde (Formol)FDA Link 01/2013
1	Fixatives (Pickling Agents)IBA 01/2013
1	Growth Factor ReceptorsIBA 03/2009
1	Fc gamma receptor IIAIBA 03/2009
1	Rituximab (Mabthera)FDA Link 03/2009
1	Chromogranin AIBA 01/2008

Therapy/Procedure

9	Therapeutics 01/2024 - 09/2006
5	Drug Therapy (Chemotherapy) 04/2023 - 09/2006
5	Immunotherapy 10/2022 - 01/2017
5	Adjuvant Chemotherapy 01/2022 - 01/2019
2	Neoadjuvant Therapy 05/2012 - 12/2011
1	Chemoradiotherapy 05/2012
1	Radiotherapy 12/2011